Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07743645 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention

Name: Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention — clinical trial record (NCT07743645)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorThe University of Texas Health Science Center, Houston

Started2026-09-01

View on ClinicalTrials.gov ↗

Amendment history

2026-09-24

Recruitment opened

The University of Texas Health Science Center, Houston

267 trials monitored

See 12 trials at risk

Schizophrenia

675 trials monitored

See 32 trials at risk

The purpose of this study is to compare the effect of a brief family-based psychosocial intervention that addresses modifiable SSD risk factors on persistent and distressing psychotic-like experiences in children and young adults with a family history of SSD and high versus low baseline SSD-like brain patterns

Trial Details

NCT Number	NCT07743645
Lead Sponsor	The University of Texas Health Science Center, Houston Collaborators: National Institutes of Health (NIH)
Conditions	Schizophrenia Spectrum Disorders (SSD)
Enrollment	100 participants
Start Date	2026-09-01
Primary Completion	2031-04-01 (estimated)
Study Completion	2031-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-23